Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CG Oncology, Inc. - Common stock
(NQ:
CGON
)
57.78
+1.36 (+2.41%)
Streaming Delayed Price
Updated: 2:16 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
388,118
Open
55.94
Bid (Size)
57.78 (300)
Ask (Size)
58.10 (400)
Prev. Close
56.42
Today's Range
55.00 - 58.25
52wk Range
14.80 - 57.88
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale
↗
February 19, 2026
This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients with limited treatment options.
Via
The Motley Fool
Topics
Regulatory Compliance
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
As the oncology community prepares to descend upon San Francisco for the 2026 ASCO Genitourinary (GU) Cancers Symposium from February 26–28, investors and clinicians alike are bracing for data that...
Via
MarketMinute
Topics
Intellectual Property
Performance
YTD
+38.3%
+38.3%
1 Month
+5.7%
+5.7%
3 Month
+41.9%
+41.9%
6 Month
+122.4%
+122.4%
1 Year
+110.0%
+110.0%
More News
Read More
What's going on in today's session
↗
January 09, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
January 09, 2026
Via
Chartmill
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
January 09, 2026
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From
CG Oncology Inc.
Via
GlobeNewswire
This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits
↗
December 29, 2025
Via
The Motley Fool
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
December 18, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
December 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock
↗
December 03, 2025
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?
↗
December 03, 2025
Via
The Motley Fool
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
CG Oncology Announces New Board Member and Board Transition
November 26, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
November 25, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover
↗
November 17, 2025
Via
The Motley Fool
CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 14, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Why Cg Oncology Stock Rocketed 7% Higher Today
↗
October 08, 2025
Via
The Motley Fool
CG Oncology Stock Signals Bullish Momentum Ahead
↗
September 08, 2025
Via
Benzinga
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
September 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Completes Enrollment in PIVOT-006
September 03, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
August 29, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Cg Oncology (CGON) Q2 Loss Widens 93%
↗
August 08, 2025
Via
The Motley Fool
Frequently Asked Questions
Is CG Oncology, Inc. - Common stock publicly traded?
Yes, CG Oncology, Inc. - Common stock is publicly traded.
What exchange does CG Oncology, Inc. - Common stock trade on?
CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for CG Oncology, Inc. - Common stock?
The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market
What is the current price of CG Oncology, Inc. - Common stock?
The current price of CG Oncology, Inc. - Common stock is 57.78
When was CG Oncology, Inc. - Common stock last traded?
The last trade of CG Oncology, Inc. - Common stock was at 02/20/26 02:16 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
